Signaling pathways
-
BA8839 AtuzabrutinibSummary: Atuzabrutinib (SAR444727) is a potent, selective reversible inhibitor. - BA8840 JS25Summary: JS25 is a selective covalent inhibitor (=5.8 nM) that is inactivated by chelation.
- BA8841 EdralbrutinibSummary: An inhibitor.
- BA8844 DD-03-171Summary: DD-03-171 is a degrading agent.
- BA8845 BTK-IN-29Summary: An inhibitor.
- BA8847 CSF1R-IN-24Summary: CSF1R-IN-24 is an orally active inhibitor.
- BA8848 EdicotinibSummary: Edicotinib (JNJ-40346527) is a potent and selective inhibitor of blood-brain permeability and oral activity.
- BA8849 SeralutinibSummary: Seralutinib is an inhalable kinase inhibitor.
- BA8850 PRN1371Summary: PRN1371 is highly selective and potent inhibitor.
- BA8851 c-Fms-IN-1Summary: c-Fms-IN-1 is a kinase inhibitor.